Dil Ltd - 506414 - Revision of Board Meeting
The Board Meeting to be held on 12/02/2019 has been revised to 12/02/201904-02-2019
04-02-2019
Dil Ltd - 506414 - Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2019
DIL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019 ,inter alia, to consider and approve unaudited financial results of the Company for the quarter and nine months ended December 31, 2019. We wish to inform you that in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 & Company''s Code of Conduct to Regulate, Monitor and Report Trading by Insiders, it is notified that the 'Trading Window" (period for trading in Company's securities) shall remain closed from Friday, February 1, 2019 to Thursday, February 14, 2019 (both days inclusive). During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's Equity Shares, either in their own name or in the name of their immediate relatives.04-02-2019
Dil Ltd - 506414 - Lease Deed With GIDC For Plot In Sayakha Industrial Estate, Gujarat
This is to inform that Company's subsidiary viz. Fermenta Biotech Limited, has signed a Lease Deed dated January 22, 2019 with Gujarat Industrial Development Corporation (GIDC) for plot T-33 + T-34 in Sayakha Industrial Estate, Gujarat for the purpose of business operations of Fermenta Biotech Limited. The copy of press release in the regard is enclosed herewith for your information and the same shall be disseminated to the public at large.23-01-2019
DIL LTD. - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Subject: Intimation of Schedule of Analysts / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with Investors and Analysts on Thursday, 3rd January 2019. This is to further inform that the Investor Presentation 'November 2018' to be discussed with Investors and Analysts in the above interaction, was uploaded on the website of the Company www.dil.net and is also available on BSE Limited website, www.bseindia.com This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.18-01-2019
DIL LTD. - 506414 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SRIKANT N SHARMADesignation :- Company Secretary and Compliance Officer17-01-2019
DIL LTD. - 506414 - Shareholding for the Period Ended December 31, 2018
Dil Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here16-01-2019
DIL LTD. - 506414 - Intimation Of Schedule Of Non - Deal Roadshow
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform that the Company officials are participating in the Non - Deal Roadshow organised by Reliance Securities Limited on January 15, 201914-01-2019
Dil Ltd - 506414 - Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we wish to inform you that there has been an upgrade in Credit Rating assigned to Fermenta Biotech Limited, Company's subsidiary, by CARE Ratings with effect from January 10, 2019. The rating also takes into account the impact of the proposed amalgamation of Fermenta Biotech Limited with the Company. Consequently, the outlook has also been changed from 'credit watch with developing implications' to 'stable'.11-01-2019
Dil Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Subject: Intimation of Schedule of Analysts / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 Pursuant to the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with Investors and Analysts on Monday, 7th January 2019. This is to further inform that the Investor Presentation 'November 2018' to be discussed with Investors and Analysts in the above interaction, was uploaded on the website of the Company www.dil.net and is also available on BSE Limited website, www.bseindia.com This information is submitted to you pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.07-01-2019
DIL LTD. - 506414 - Intimation Regarding Receipt Of Awards By Fermenta Biotech Limited, Company'S Subsidiary
We would like to inform that Fermenta Biotech Limited, Company's subsidiary, has received 'Excellence in Corporate Social Responsibility', 'Excellence in Export Promotion' and 'Pharma International Excellence' awards at India Pharma Awards 2018. Award details and related information is enclosed herewith for the information of stakeholders.31-12-2018